Allevi and Lonza , a major Swiss CDMO, have formed a collaboration to bring the elements needed for 3D bioprinting together. Combining Lonza’s primary cells and media with Allevi’s 3D bioprinters and bioink production capabilities will empower researchers with the tools needed for plug-and-play bioprinting.

 .

One of the biggest setbacks on bioprinting advancements is the availability of viable and functional cellular materials. Much like in AM, the technologies may be slow but they are there and ready for creating commercial applications, they are just not been exploited to the fullest.

 .

Allevi is one of the companies developing affordable bioprinting hardware and is dedicated to providing high-quality materials for every step of the 3D bioprinting workflow, making it easy to design, engineer, and manufacture 3D tissues. Their 3D bioprinters and bioinks are used by leading researchers globally in research drug discovery and tissue engineering. Lonza Biosciences is a global leader […]

Click here to view original web page at www.3dprintingmedia.network